Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Sirnaomics Ltd. ( (HK:2257) ) is now available.
Sirnaomics Ltd. has announced the composition of its board of directors, detailing the roles and functions of each member. The board includes executive, non-executive, and independent non-executive directors, with specific members assigned to the audit, nomination, and remuneration committees. This announcement provides clarity on the governance structure of the company, which is crucial for stakeholders and investors to understand the leadership dynamics and decision-making processes within the organization.
The most recent analyst rating on (HK:2257) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Sirnaomics Ltd. stock, see the HK:2257 Stock Forecast page.
More about Sirnaomics Ltd.
Sirnaomics Ltd. is a biotechnology company incorporated in the Cayman Islands, focusing on the development of RNAi therapeutics for the treatment of various diseases. The company is listed on the stock exchange under the code 2257.
Average Trading Volume: 927,038
Technical Sentiment Signal: Sell
Current Market Cap: HK$867.8M
For an in-depth examination of 2257 stock, go to TipRanks’ Overview page.